NCT06098066

Brief Summary

In the high-stakes battle against ischemic cerebrovascular disease, where every second counts and the margin for error is slim, how do the investigators tip the scales in favor of patient survival and improved outcomes? This groundbreaking study, the first nationwide, population-based analysis with long-term follow-up in an Asian context, dives deep into this critical question. Leveraging an expansive dataset from Taiwan's National Health Insurance Research Database, the investigators scrutinize the efficacy and risks of aggressive surgical interventions-specifically, EC-IC bypass, CEA, and CAS-in a cohort of over 84,000 patients. This paper serves as a milestone, bridging the gap between medical idealism and clinical reality. It calls for a surgical renaissance, emphasizing the need for refining techniques and enhancing patient selection protocols. If participants're looking for a comprehensive, nuanced, and, above all, actionable insight into the surgical treatment of ischemic cerebrovascular disease, this is the study that could redefine the paradigm.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
204,411

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2020

Completed
29 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2020

Completed
2.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2023

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

October 9, 2023

Completed
15 days until next milestone

First Posted

Study publicly available on registry

October 24, 2023

Completed
Last Updated

October 24, 2023

Status Verified

October 1, 2023

Enrollment Period

29 days

First QC Date

October 9, 2023

Last Update Submit

October 18, 2023

Conditions

Keywords

Ischemic Cerebrovascular DiseaseEC-IC BypassCarotid EndarterectomyCarotid Artery StentingNationwide Cohort StudyRisk-Benefit Analysis

Outcome Measures

Primary Outcomes (1)

  • rehospitalization

    rehospitalization due to ischemic or hemorrhagic stroke

    Follow-up assessments were planned at 3 months, 6 months, 1 year, 2 years, and 3 years post-index date

Secondary Outcomes (1)

  • Cardiac events

    Follow-up assessments were planned at 3 months, 6 months, 1 year, 2 years, and 3 years post-index date

Study Arms (4)

control

ECIC bypass

CEA

CAS

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The cohort comprises all inpatients hospitalized between January 1, 2001, and December 31, 2010, diagnosed with a first stenosis-occlusion ischemic stroke (ICD-9-CM codes 433-434). All participants underwent either a computed tomography (CT) scan or magnetic resonance imaging (MRI) within two days before or after hospital admission.

You may qualify if:

  • \- All participants underwent either a computed tomography (CT) scan or magnetic resonance imaging (MRI) within two days before or after hospital admission.
  • The date of the first ischemic stroke hospitalization served as the index event.
  • Among these patients, those who underwent surgical interventions post-hospitalization were categorized into three distinct groups: CEA (ICD-9-CM code 3812), CAS (ICD-9-CM code 3990), and EC-IC (ICD-9-CM code 3928), with the operation date being the index date.
  • Those who did not receive any surgical interventions were considered the non-intervention control group and had their first hospitalization date as the index date.

You may not qualify if:

  • \- patients with a history of: any stroke subtype (ICD-9-CM codes 430-434), Moyamoya disease (ICD-9-CM code 437.5), cancer (ICD-9-CM codes 140-239), trauma (various ICD-9-CM codes), transient ischemic attack (ICD-9-CM code 435), unruptured cerebral aneurysm (ICD-9-CM code 437.3), or subarachnoid hemorrhage (ICD-9-CM code 430).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

China Medical University Hospital

Taichung, Taiwan

Location

MeSH Terms

Conditions

Ischemic Stroke

Condition Hierarchy (Ancestors)

StrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Researcher

Study Record Dates

First Submitted

October 9, 2023

First Posted

October 24, 2023

Study Start

May 1, 2020

Primary Completion

May 30, 2020

Study Completion

January 31, 2023

Last Updated

October 24, 2023

Record last verified: 2023-10

Locations